Faecal transplant given in oral capsule reduces recurrent C difficile, shows studyBMJ 2017; 359 doi: https://doi.org/10.1136/bmj.j5501 (Published 28 November 2017) Cite this as: BMJ 2017;359:j5501
- Susan Mayor
Faecal microbiota transplantation delivered orally in a capsule prevents recurrent Clostridium difficile infection in at-risk adults as effectively as transplantation of donor stool material by colonoscopy, a randomised trial has found.1
Infection with C difficile is the leading cause of healthcare associated infectious diarrhoea and recurrent infection is common. Between 10% and 30% of patients have a recurrence and this risk increases to 60% after the third episode.
Faecal microbiota transplantation, which involves giving faecal matter from a healthy donor, …